Skip to main content
curacle co., ltd. logo

curacle co., ltd. — Investor Relations & Filings

Ticker · 365270 ISIN · KR7365270008 KO Professional, scientific and technical activities
Open in API
Filings indexed 203 across all filing types
Latest filing 2025-05-28 Capital/Financing Update
Country KR South Korea
Listing KO 365270

About curacle co., ltd.

http://www.curacle.com/eng/main/

Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity'. It details the specific terms of the bond acquisition, including the amount, date, and reason (negotiated early acquisition). This falls under capital structure changes and financing updates, specifically related to the company's debt instruments. Given the specific nature of the filing regarding capital structure and debt management, 'CAP' (Capital/Financing Update) is the most accurate classification.
2025-05-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a corporate presentation/NDR). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is a regulatory disclosure of an event, it falls under the category of general regulatory announcements.
2025-05-26 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for Curacle Co., Ltd. It details the terms of a rights offering, including share allocation methods, subscription periods, and underwriting details. This document is a formal regulatory filing in Korea (DART system) concerning capital structure changes and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most accurate category for announcements regarding new share issues and capital changes.
2025-05-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Curacle Co., Ltd. regarding a 'Capital Increase' (유상증자결정). It details the terms of a rights offering, including share issuance, pricing methods, subscription dates, and underwriting details. This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-05-22 Korean
증권신고서(지분증권) (2025.07)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed by Curacle Co., Ltd. with the Financial Services Commission of South Korea. It details a capital increase (rights offering/public offering), including information on the number of shares, investment risks, financial status, and management details. This is a formal regulatory filing required for capital raising activities, which falls under the 'Capital/Financing Update' category.
2025-05-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정), outlining the number of new shares, purpose of funds, issuance price calculation methods, and subscription schedules. This falls under the category of capital structure changes and share issuance.
2025-05-16 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.